Как мы стареем

17 Roselli, C., Ramaswami, M., Boto, T., Cervantes-Sandoval, I. 2021. “The Making of Long-Lasting Memories: A Fruit Fly Perspective”. Frontiers in Behavioral Neuroscience 15:662129, https://doi.org/10.3389/fnbeh.2021.662129; Yin, J. C., et al. 1994. “Induction of a Dominant Negative CREB Transgene Specifically Blocks Long-Term Memory in Drosophila”. Cell 79:49–58, https://doi.org/10.1016/0092–8674 (94) 90399–9; Dubnau, J., et al. 2003. “The Staufen/Pumilio Pathway Is Involved in Drosophila Long-Term Memory”. Current Biology 13:286–96, https://doi.org/10.1016/s0960–9822 (03) 00064–2.

18 Dash, P. K., Hochner, B., Kandel, E. R. 1990. “Injection of the cAMP-Responsive Element into the Nucleus of Aplysia Sensory Neurons Blocks Long-Term Facilitation”. Nature 345:718–21, https://doi.org/10.1038/345718a0.

19 Arey, Murphy 2017.

20 Kauffman et al. 2010; Kauffman, A., et al. 2011. “C. elegans Positive Butanone Learning, Short-Term, and Long-Term Associative Memory Assays”. Journal of Visualized Experiments, no. 49, 2490, https://doi.org/10.3791/2490.

21 Kauffman et al. 2010, 2011.

22 Kauffman et al. 2010; Li et al. 2016; Lakhina, V., et al. 2015. “Genome-wide Functional Analy sis of CREB/Long-Term Memory-Dependent Transcription Reveals Distinct Basal and Memory Gene Expression Programs”. Neuron 85:330–45, https://doi.org/10.1016/j.neuron.2014.12.029; Arey, R. N., Stein, G. M., Kaletsky, R., Kauffman, A., Murphy, C. T. 2018. “Activation of Galphaq Signaling Enhances Memory Consolidation and Slows Cognitive Decline”. Neuron 98:562–74.e5, https://doi.org/10.1016/j.neuron.2018.03.039; Arey, R. N., Kaletsky, R., Murphy, C. T. 2019. “Nervous System-wide Profiling of Presynaptic mRNAs Reveals Regulators of Associative Memory”. Scientific Reports 9:20314, https://doi.org/10.1038/s41598019-56908-8; Stein, G. M., Murphy, C. T. 2012. “The Intersection of Aging, Longevity Pathways, and Learning and Memory in C. elegans”. Frontiers in Genetics 3:259, https://doi.org/10.3389/fgene.2012.00259; Stein, G. M., Murphy, C. T. 2014. “C. elegans Positive Olfactory Associative Memory Is a Molecularly Conserved Behavioral Paradigm”. Neurobiology of Learning and Memory 115:86–94, https://doi.org/10.1016/j.nlm.2014.07.011.

23 Arey, Kaletsky, Murphy 2019.

24 Kauffman et al. 2010.

25 О повышении уровня CREB: Kauffman et al. 2010. Об aктивaторaх CREB: Arey et al. 2018.

26 Arey et al. 2018.

27 Villeda, S. A., et al. 2014. “Young Blood Reverses Age-Related Impairments in Cognitive Function and Synaptic Plasticity in Mice”. Nature Medicine 20:659–63, https://doi. org/10.1038/nm.3569; Villeda, S. A., et al. 2011. “The Ageing Systemic Milieu Negatively Regulates Neurogenesis and Cognitive Function”. Nature 477:90–94, https://doi.org/10.1038/nature10357.

28 White, C. W., 3rd, et al. 2020. “Age-Related Loss of Neural Stem Cell O-GlcNAc Promotes a Glial Fate Switch through STAT3 Activation”. Proceedings of the National Academy of Sciences of the USA 117:22214–24, https://doi.org/10.1073/pnas.2007439117; Gontier, G., et al. 2018. “Tet2 Rescues Age-Related Regenerative Decline and Enhances Cognitive Function in the Adult Mouse Brain”. Cell Reports 22:1974–81, https://doi.org/10.1016/j.celrep.2018.02.001; Smith, L. K., et al. 2015. “Beta2-Microglobulin Is a Systemic Pro-aging Factor that Impairs Cognitive Function and Neurogenesis”. Nature Medicine 21:932–37, https://doi.org/10.1038/nm.3898; Bouchard, J., Villeda, S. A. 2015. “Aging and Brain Rejuvenation as Systemic Events”. Journal of Neurochemistry 132:5–19, https://doi.org/10.1111/jnc.12969.

29 Lin, T. et al. 2018. “Systemic Inflammation Mediates Age-Related Cognitive Deficits”. Frontiers in Aging Neuroscience 10:00236, https://doi.org/10.3389/fnagi.2018.00236.

30 Reddy, O. C., van der Werf, Y. D. 2020. “The Sleeping Brain: Harnessing the Power of the Glymphatic System through Lifestyle Choices”. Brain Sciences 10:868, https://doi.org/10.3390/brainsci10110868.

31 Horowitz, A. M., et al. 2020. “Blood Factors Transfer Beneficial Effects of Exercise on Neurogenesis and Cognition to the Aged Brain”. Science 369:167–73, https://doi.org/10.1126/science.aaw2622.

32 De Miguel, Z., et al. 2021. “Exercise Plasma Boosts Memory and Dampens Brain Inflammation via Clusterin”. Nature 600:494–99, https://doi.org/10.1038/s41586-021-04183-x.

33 Yao, V., et al. 2018. “An Integrative Tissue-Network Approach to Identify and Test Human Disease Genes”. Nature Biotechnology 36:1091–99, https://doi.org/10.1038/nbt.4246.

34 Cohen, E., et al. 2009. “Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice”. Cell 139:1157–69, https://doi.org/10.1016/j.cell.2009.11.014; Cohen, E., Dillin, A. 2008. “The Insulin Paradox: Aging, Proteotoxicity and Neurodegeneration”. Nature Reviews Neuroscience 9:759–67, https://doi.org/10.1038/nrn2474.

35 Gabriele, R. M. C., Abel, E., Fox, N. C., Wray, S., Arber, C. 2022. “Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities”. Frontiers in Neuroscience 16:835645, https://doi.org/10.3389/fnins.2022.835645.

36 Kessissoglou, I. A., et al. 2020. “The Drosophila Amyloid Precursor Protein Homologue Mediates Neuronal Survival and Neuroglial Interactions”. PLOS Biology 18: e3000703, https://doi.org/10.1371/journal.pbio.3000703.

37 Gabriele et al. 2022.

38 Lee, W. J., et al. 2022. “Regional Aβ-Tau Interactions Promote Onset and Acceleration of Alzheimer’s Disease Tau Spreading”. Neuron 110:1932–43.e5, https://doi.org/10.1016/j.neuron.2022.03.034.

39 Li, T., Cao, H. X., Ke, D. 2021. “Type 2 Diabetes Mellitus Easily Develops into Alzheimer’s Disease via Hyperglycemia and Insulin Resistance”. Current Medical Science 41:1165–71, https://doi.org/10.1007/s11596-021-2467-2.

40 Lopez-Rodriguez, A. B., et al. 2021. “Acute Systemic Inflammation Exacerbates Neuroinflammation in Alzheimer’s Disease: IL-1β Drives Amplified Responses in Primed Astrocytes and Neuronal Network Dysfunction”. Alzheimer’s and Dementia 17:1735–55, https://doi.org/10.1002/alz.12341.

41 Grundke-Iqbal, I., et al. 1986. “Microtubule-Associated Protein Tau: A Component of Alzheimer Paired Helical Filaments”. Journal of Biological Chemistry 261:6084–89.

42 Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., Hyman, B. T. 1992. “Neurofibrillary Tangles but Not Senile Plaques Parallel Duration and Severity of Alzheimer’s Disease”. Neurology 42:631–39, https://doi.org/10.1212/wnl.42.3.631.

43 Novak, P., et al. 2021. “ADAMANT: A Placebo-Controlled Randomized Phase 2 Study of AADvac1, an Active Immunotherapy against Pathological Tau in Alzheimer’s Disease”. Nature Aging 1:521–34, https://doi.org/10.1038/s43587-021-00070-2.

44 Spires-Jones, T. L., Hyman, B. T. 2014. “The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease”. Neuron 82:756–71, https://doi.org/10.1016/j.neuron.2014.05.004.

45 Goedert, M. 2018. “Tau Filaments in Neurodegenerative Diseases”. FEBS Letters 592:2383–91, https://doi.org/10.1002/1873–3468.13108; Yoshiyama, Y., et al. 2007. “Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model”. Neuron 53:337–51, https://doi.org/10.1016/j.neuron.2007.01.010.

46 Spires-Jones, Hyman 2014.

47 Largo-Barrientos, P., et al. 2021. “Lowering Synaptogyrin-3 Expression Rescues Tau-Induced Memory Defects and Synaptic Loss in the Presence of Microglial Activation”. Neuron 109:767–77.e5, https://doi.org/10.1016/j.neuron.2020.12.016.

48 Gorbunova, V., et al. 2021. “The Role of Retrotransposable Elements in Ageing and Age-Associated Diseases”. Nature 596:43–53, https://doi.org/10.1038/s41586-021-03542-y.

49 Chang, Y. H., Dubnau, J. 2019. “The Gypsy Endogenous Retrovirus Drives Non-cell-autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration”. Current Biology 29:3135–52.e4, https://doi.org/10.1016/j.cub.2019.07.071; Guo, C., et al. 2018. “Tau Activates Transposable Elements in Alzheimer’s Disease”. Cell Reports 23:2874–80, https://doi.org/10.1016/j.celrep.2018.05.004.

50 Ramirez, P., et al. 2021. “Pathogenic Tau Accelerates Aging-Associated Activation of Transposable Elements in the Mouse Central Nervous System”. Progress in Neurobiology 208:102181, https://doi.org/10.1016/j.pneurobio.2021.102181; Guo, C., et al. 2018. “Tau Activates Transposable Elements in Alzheimer’s Disease”. Cell Reports 23:2874–80, https://doi.org/10.1016/j.celrep.2018.05.004.

51 Tam, O. H., Ostrow, L. W., Gale Hammell, M. 2019. “Diseases of the Nervous System: Retrotransposon Activity in Neurodegenerative Disease”. Mobile DNA 10:32, https://doi.org/10.1186/s13100-019-0176-1.

52 Guengerich, P. 2020. “Repurposing an HIV Drug to Treat Alzheimer’s”. Discover, January 29, 2020, https://discover.vumc.org/2020/01/repurposing-an-hiv-drug-to-treat-alzheimers/; Stulpin, C. 2020. “ART Reduces Alzheimer’s Prevalence among Patients with HIV”. Healio News, October 8, 2020, https://www.healio.com/news/infectious-disease/20201008/art-reduces-alzheimers-prevalence-among-patients-with-hiv; Mast, N., Verwilst, P., Wilkey, C. J., Guengerich, F. P., and Pikuleva, I. A., 2020. “In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds”. Journal of Medicinal Chemistry 63:6477–88, https://doi.org/10.1021/acs.jmedchem.9b01383.

53 Gold, J., et al. 2019. “Safety and Tolerability of Triumeq in Amyotrophic Lateral Sclerosis: The Lighthouse Trial”. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:595–604, https://doi.org/10.1080/21678421.2019.1632899.

54 Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., Bu, G. 2019. “Apolipoprotein E and Alzheimer Disease: Pathobiology and Targeting Strategies”. Nature Reviews Neurology 15:501–18, https://doi.org/10.1038/s41582-019-0228-7.

55 Park, J. E., et al. 2022. “Diagnostic Blood Biomarkers in Alzheimer’s Disease”. Biomedicines 10:169, https://doi.org/10.3390/biomedicines10010169; Hardy-Sosa, A., et al. 2022. “Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review”. Frontiers in Aging Neuroscience 14:683689, https://doi.org/10.3389/fnagi.2022.683689.

56 Нaционaльный институт стaрения, “How Is Alzheimer’s Disease Treated?”, версия от 20 декaбря 2022 г., https://www.nia.nih.gov/health/how-alzheimers-disease-treated.

57 Hashimoto, M., et al. 2005. “Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients with Alzheimer’s Disease?” American Journal of Psychiatry 162:676–82, https://doi.org/10.1176/appi.ajp.162.4.676.

58 Cacabelos, R. 2007. “Donepezil in Alzheimer’s Disease: From Conventional Trials to Pharmacogenetics”. Neuropsychiatric Disease and Treatment 3:303–33.

59 Makin, S. 2018. “The Amyloid Hypothesis on Trial”. Nature 559: S4–7, https://doi.org/10.1038/d41586-018-05719-4.